Oncotelic Therapeutics Inc (OTLC) is a biotechnology company listed on OTCQB.
Latest reported OTLC revenue for 2026-06-30 was $250.0K. Net income was -$1.8M. OTLC currently screens at market cap $17.8M and trailing P/E 0.1.
Use this OTLC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OTLC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OTLC SEC filings page. Lician reads the product cache first so this HTML stays unique to Oncotelic Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full OTLC income, balance, and cash tables.